Authors


Briana Contreras

Latest:

Walmart Expanding Their Efforts to Care for HIV Community

Walmart has opened 70 Specialty Pharmacies of the Community locations across the U.S. in June, and is expected to open 80 more in 11 states by the end of the year.


Sara Goldman, OptimizeRx

Latest:

Harnessing Digital at the Point of Care

Taking advantage of new advances in tech-driven engagement to boost patient support and adherence


Rob Besse, Archbow Consulting

Latest:

Are ADMs a Viable Option for Pharma?

The key questions and considerations for drug manufacturers pursuing an effective alternative distribution model.


Lee Feander

Latest:

Postponement: A Vital Supply Strategy

Drugmakers can turn to postponement, or late-stage customization, to help adapt approaches along the supply chain


Martha M. Rumore, Frier Levitt, LLC

Latest:

2023 challenges of the Drug Supply Chain Security Act implementation on wholesale drug distributors

Exploring new guidances and future challenges for pharma trading partners in meeting looming DSCSA mandates in the US


Jaya White, Edward Rickert, Richard Davis

Latest:

Navigating Abortion Restrictions Post Dobbs: Considerations for Pharmacy Providers

As a result of the United States Supreme Court’s overturning of Roe v. Wade and Planned Parenthood v. Casey, pharmacy providers are looking to state laws and other recently issued federal guidance in determining how they can compliantly meet patient needs and deliver medications.


Susan Haigney

Latest:

FDA Issues Guidance on Biosimilar Labeling

The draft guidance document discusses the development of labeling for proposed biosimilars and interchangeable biosimilars for submission under section 351(k) of the Public Health Service Act.


David Laros, Beghou Consulting

Latest:

Transforming the Patient Hub into a Hub of Patient Centricity

Methods that pharma companies can use to make the hub more personalized and experiential.


Stephen Brengle

Latest:

The Role and Recruitment of the Chief Patient Officer

New C-Suite position emerges for more emphasis on patient centricity


Jill Murphy

Latest:

Ten23 Expands Sterile Manufacturing Capacity at VIVA 1 Facility

Further expansions of the pharmaceutical development and manufacturing services of ten23 are happening at the BASE and VIVA facilities to continue to support complex sterile product development, testing, and manufacturing.


Julian Upton

Latest:

Insights on Insight Gathering

Understanding markets, influencers, and patients through better stakeholder engagement and faster analysis


Bill Roth, IntegriChain

Latest:

Who Moved My Prescription? Part II

An analysis of the two main new models for pharmacy—unique direct—to-consumer for brands and cash pay for generics—and what members of industry think about them.


Bill Barr, Carl Hart, and Zack Blaker

Latest:

Reimbursement-Related Analytics and Reporting

An overview of a structural approach that guides development of the analytics and related reporting that may assist brands in gaining or maintaining reimbursement positions and maximizing sales.



Micah Benford

Latest:

Patient Assistance Programs Pharmacy Options

Choosing the right pharmacy to administer the program involves a number of factors.


Tyson Stuelpe

Latest:

In New Year, Resolve to Solve Drug Supply Chain Security Act Compliance

Under the DSCSA law, wholesale distributors, re-packagers, dispensers, and other third-party logistics providers must implement interoperable and electronic tracing of prescription products at the package level.


Ellinor Grape

Latest:

Making Cold Chain More Sustainable

How can pharma manufacturers and distributors balance logistical demands and environmental impact?


Kris Soyoung Lee, Samsung Bioepis

Latest:

ESG is Reshaping the Supply Chain

Six steps pharma organizations can follow to help achieve sustainability in their product supply chains



RareMed Solutions

Latest:

Disruption without interruption: Transitioning Rare Disease HUB & NCP Programs

Transitioning a rare disease HUB or NCP program to a rare-focused partner can yield major service quality improvements without program disruption.


Chris Reynolds

Latest:

Rethinking Pharma Commercialization Models as Healthcare Evolves

How cross-functional commercialization teams can hone their role within clinical management pathways, communicate value to all stakeholders, achieve excellence in evidence generation, and maximize the opportunities of digital technologies


Ashley Herrick and Nicole Carswell, Premier Research

Latest:

Empowering Patients in Oncology Trials

Creating positive experiences and other patient-focused strategies for sponsors to consider when planning and executing cancer studies


Huan Tan, Beghou Consulting

Latest:

The Value of ML in Customer Targeting

How biopharma commercial teams can leverage machine learning techniques to improve targeting of HCPs and patients


Sandra Anderson

Latest:

Commercializing Cell and Gene Therapies in Canada

Sandra Anderson outlines what manufacturers need to know about the regulatory environment and commercialization solutions for the Canadian market.


Kilian Weiss

Latest:

Your Engagement Strategy is Only as Good as Your Data

Leaders from Janssen, Novartis Gene Therapies, Pierre Fabre, and the German cancer app start-up Mika discuss how they are leveraging data in innovative ways to advance their engagement with the scientific community and their overall commercial operations


Sarah Eckenrode, PhD, Azenta Life Sciences

Latest:

Building a Robust Cold Chain for CGTs

Strategies to boost the reproducibility and traceability of cell and gene therapies for more effective clinical studies and commercialization



Ajeet Gajra, Cardinal Health

Latest:

Getting to answers about Biogen’s Aduhelm

Exploring RCT, RWE and alternative study designs as a path forward


Beena Wood

Latest:

Advancing PV Operations and Patient Safety through Innovation

How digital adoption is driving pharmacovigilance


© 2024 MJH Life Sciences

All rights reserved.